CORMORANT’S FANCY, a Celtic folk band playing traditional Irish and Scottish music, will perform for the Fine Arts at First Artist Series at First Lutheran Church, 21 South Bedford Street, Carlisle, on Sunday, March 11 at 3 P.M.  The concert will benefit the breast cancer research of Susan G. Komen for the Cure.  

Featuring concertina, fiddle, penny whistles, low whistles, guitar, bodhran, and vocals, the band will perform a variety of jigs, reels, hornpipes, polkas, and slow airs as well as sing favorite Irish songs including Arthur McBride, The Minstrel Boy, and P Stands for Paddy.  The audience will be invited to join in such sing-alongs as Molly Malone, Red is the Rose, and I’ll Tell Me Ma, and the children will be asked to play shakers with the band on selected tunes.

Based in south-central Pennsylvania, Cormorant’s Fancy has been characterized as "the area's most energetic and spellbinding Irish folk band".  It has been performing monthly as the house band for the Historic Fairfield Inn since 2003 when it was formed.  Several of the musicians have Irish and Scottish roots.  One of the band’s founding members, the Rev. Dr. Stephen P. Folkemer, is the Director of Music and Professor of Church Music and Cantor at the Lutheran Theological Seminary at Gettysburg. 

The concert is free and open to the public.  All offering received will be donated to Susan G. Komen for the Cure.  Thrivent Financial for Lutherans will provide supplemental funding towards the money raised at the concert.  A dessert reception will follow the performance where the band’s CDs, An Evening at the Fairfield Inn and Here and There, will be available for purchase.  Doors will open at 2:15 p.m.  For information, contact the church, 717-249-3310, or visit www.firstlutherancarlisle.org . 

We hope to see you for a celebration of Celtic music in the month of March!  You will also be supporting the work of Susan G. Komen for the Cure knowing that the total offering collected at the performance will be donated to this non-profit organization fighting breast cancer.